Evidence synthesis, digital scribes, and translational challenges for artificial intelligence in healthcare.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 36513071.
- Also identified by DOI 10.1016/j.xcrm.2022.100860 and PMC identifier 9798027.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Healthcare has well-known challenges with safety, quality, and effectiveness, and many see artificial intelligence (AI) as essential to any solution. Emerging applications include the automated synthesis of best-practice research evidence including systematic reviews, which would ultimately see all clinical trial data published in a computational form for immediate synthesis. Digital scribes embed themselves in the process of care to detect, record, and summarize events and conversations for the electronic record. However, three persistent translational challenges must be addressed before AI is widely deployed. First, little effort is spent replicating AI trials, exposing patients to risks of methodological error and biases. Next, there is little reporting of patient harms from trials. Finally, AI built using machine learning may perform less effectively in different clinical settings.
Medical subject headings
- Artificial Intelligence
- Machine Learning